Human antithrombin III-derived heparin-binding peptide, a novel heparin antagonist (Q44597765)

4 December 2017

Human antithrombin III-derived heparin-binding peptide, a novel heparin antagonist (English)

1 reference

4 December 2017

1 reference

Satomi Onoue

1

1 reference

4 December 2017

Yoshitaka Nemoto

2

1 reference

4 December 2017

Sunao Harada

3

1 reference

4 December 2017

Takehiko Yajima

4

1 reference

4 December 2017

Kazuhisa Kashimoto

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

17 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511765

full work available at URL

14 March 2024

https://api.elsevier.com/content/article/PII:S0024320503007057?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0024-3205(03)00705-7

https://api.elsevier.com/content/article/PII:S0024320503007057?httpAccept=text/plain

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0024-3205(03)00705-7

14 March 2024

1 reference

4 December 2017

73

1 reference

4 December 2017

22

1 reference

4 December 2017

2793-2806

1 reference

Interaction of heparin with synthetic antithrombin III peptide analogues

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Heparin potentiation of 3T3-adipocyte stimulated angiogenesis: mechanisms of action on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Synthetic magainin analogues with improved antimicrobial activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Structural studies on a biologically active hexasaccharide obtained from heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

On the domain structure of antithrombin III. Tentative localization of the heparin binding region using 1H NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Computed circular dichroism spectra for the evaluation of protein conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

The anticoagulant activation of antithrombin by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

A comparison of the strength of binding of antithrombin III, protamine and poly(L-lysine) to heparin samples of different anticoagulant activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Inhibition of bovine factor IXa and factor Xa.beta. by antithrombin III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Mapping and quantification of the major oligosaccharide components of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Modulation of magainin 2-lipid bilayer interactions by peptide charge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

The complete amino acid sequence of bovine antithrombin (ATIII).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Antithrombin III: structural and functional aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment 106-126.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

A new member of the plasma protease inhibitor gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Human endothelial cells: use of heparin in cloning and long-term serial cultivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Conformational and functional study of magainin 2 in model membrane environments using the new approach of systematic double-D-amino acid replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900705-7

Sensitivity and Specificity of Plasma Serine Protease Chromogenic Substrates

7 January 2021

2

1 reference

https://api.crossref.org/works/10.1016/S0024-3205(03)00705-7

Antithrombin: structure and function

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0024-3205(03)00705-7

14 March 2024

Identifiers

1 reference

4 December 2017

1 reference